Cardiac malformations in children with congenital hypothyroidism

M Scavone1, V Tallarico1, E Stefanelli1

  • 1Pediatric Unit, Department of Science of Health, University Magna Graecia of Catanzaro, Catanzaro, Italy.

Insights

Congenital hypothyroidism (CH) in infants is linked to a high rate of congenital heart defects (CD). Routine echocardiography is crucial for early diagnosis and management of these cardiac issues in CH patients.

Area of Science:

  • Pediatric Endocrinology
  • Cardiology
  • Genetics

Background:

  • Congenital hypothyroidism (CH) is a common endocrine disorder in children.
  • Infants with CH have a higher incidence of congenital malformations (CM), particularly cardiac defects (CD).

Purpose of the Study:

  • To determine the prevalence of cardiac defects (CD) in infants diagnosed with congenital hypothyroidism (CH).
  • To assess the necessity of routine echocardiography for early detection of CD in CH patients.

Main Methods:

  • Retrospective analysis of medical records for 255 infants screened for CH between 1991 and 2016.
  • Clinical examination for heart murmurs and dysmorphic features, alongside echocardiography and cardiological evaluation.
  • Final analysis included 191 patients, examining thyroid gland status (eutopic vs. dysgenesis) and presence of CD.

Main Results:

  • 13.6% (26/191) of infants with CH presented with cardiac defects (CD).
  • Atrial septal defect (ASD) was the most common anomaly (65.4% of CD cases), followed by VSD, PDA, and others.
  • No significant association was found between CD frequency and sex, CH type, or TSH levels.

Conclusions:

  • There is a high prevalence of cardiac defects (CD) in infants with congenital hypothyroidism (CH).
  • Routine echocardiography is recommended for all infants with CH to facilitate early diagnosis and management of associated cardiac anomalies.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
234
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.6K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
347
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
208